IMMY买入原因:今天IMMY发的干眼症药物为Restasis的仿制药,RESTASIS 2016年第三季度全球销售额为371.6million, 第四季度全球销售额393.1 million占干眼症市场的80%,现有竞争对手仅有Shire’s idra,占20%的市场。IMMY的仿制药由于是走低价路线,有可...查看全文
TLS美股研究2017-04-09 21:31
回复@panderson: $IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 我们看看。我刚打赏了这条评论 ¥2.88,也推荐给你。//@panderson:回复@TLS美股研究:IMMY值得关注,眼科市场天花板逐渐打开,公司高管参与增发,市值迷你,会是小黑马吗 查看全文
$Harrow Health(IMMY)$ 8-K - Current report Filed: 2019-03-18 AccNo: 0001493152-19-003523 Size: 2 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Harrow Health(IMMY)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-12 AccNo: 0001493152-19-003188 Size: 6 MB 网页链接
$Harrow Health(IMMY)$ 8-K - Current report Filed: 2019-03-12 AccNo: 0001493152-19-003190 Size: 80 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Harrow Health(IMMY)$ 8-K - Current report Filed: 2019-03-04 AccNo: 0001493152-19-002803 Size: 2 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Harrow Health(IMMY)$ 8-K - Current report Filed: 2019-02-25 AccNo: 0001493152-19-002482 Size: 28 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Harrow Health(IMMY)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001493152-19-002112 Size: 179 KB 网页链接
$Harrow Health(IMMY)$ 8-K - Current report Filed: 2019-02-07 AccNo: 0001493152-19-001547 Size: 28 KBItem 1.01: Entry into a Material Definitive Agreement 网页链接
$Harrow Health(IMMY)$ 8-K - Current report Filed: 2019-02-05 AccNo: 0001493152-19-001358 Size: 197 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Harrow Health(IMMY)$ 内部交易: 2019-01-02,Director,Kammer Robert J ,卖出,10000普通股, $5.33
$Harrow Health(IMMY)$ 8-K - Current report Filed: 2018-12-31 AccNo: 0001493152-18-018103 Size: 87 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接